NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 313 filers reported holding NOVOCURE LTD in Q4 2022. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,450 | -65.9% | 709 | -12.4% | 0.00% | -100.0% |
| Q2 2023 | $33,574 | -31.0% | 809 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $48,653 | -18.0% | 809 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $59,340 | -2.7% | 809 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $61,000 | +5.2% | 809 | -3.6% | 0.00% | 0.0% |
| Q2 2022 | $58,000 | -18.3% | 839 | -2.3% | 0.00% | 0.0% |
| Q1 2022 | $71,000 | +10.9% | 859 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $64,000 | -48.8% | 859 | -20.4% | 0.00% | -50.0% |
| Q3 2021 | $125,000 | -49.6% | 1,079 | -3.6% | 0.00% | -50.0% |
| Q2 2021 | $248,000 | -99.9% | 1,119 | -53.1% | 0.00% | +33.3% |
| Q1 2021 | $315,646,000 | +144030.6% | 2,388 | +88.9% | 0.00% | -40.0% |
| Q4 2020 | $219,000 | +895.5% | 1,264 | +532.0% | 0.01% | +400.0% |
| Q3 2020 | $22,000 | +83.3% | 200 | 0.0% | 0.00% | – |
| Q2 2020 | $12,000 | -7.7% | 200 | 0.0% | 0.00% | – |
| Q1 2020 | $13,000 | -18.8% | 200 | 0.0% | 0.00% | – |
| Q4 2019 | $16,000 | +14.3% | 200 | 0.0% | 0.00% | – |
| Q3 2019 | $14,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $77,833,000 | 15.51% |
| HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
| Darsana Capital Partners LP | 700,000 | $155,274,000 | 4.42% |
| MORGAN JESS S & CO INC | 23,775 | $5,274,000 | 3.47% |
| Soleus Capital Management, L.P. | 98,975 | $21,955,000 | 3.38% |
| Montanaro Asset Management Ltd | 116,650 | $25,875,000 | 3.26% |
| Taylor Frigon Capital Management LLC | 31,035 | $6,884,000 | 2.15% |
| Rhenman & Partners Asset Management AB | 120,000 | $26,618,000 | 1.81% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $2,218,000 | 1.33% |
| Derbend Asset Management | 5,789 | $1,284,000 | 1.20% |